PANRE study materials
PANRE study resources

A Negative H. pylori Test on a PPI: Interpreting a Test That Was Set Up to Fail

PANRE · Put your knowledge to work in context.

All case studies

A Negative H. pylori Test on a PPI: Interpreting a Test That Was Set Up to Fail

A 52-year-old man has 10 weeks of burning epigastric pain that worsens before meals and eases with food. Omeprazole 20 mg daily was started six weeks ago, with maybe 40% improvement. A stool antigen test drawn last week - while he was still taking omeprazole - is negative. He takes naproxen two to three times weekly for back pain, drinks two beers nightly, and has lost 8 lb because he has been eating less. He reports no dysphagia, no vomiting, no melena, and no early satiety. Hemoglobin is 14.2 g/dL, platelets 240,000. He was told he had a "childhood allergy" to amoxicillin (rash only). He asks whether he "just has an ulcer" and whether he needs a scope.

1. How do you interpret the negative stool antigen test, and what do you do about it?

Read the worked answer

The result is uninterpretable and must be repeated under proper conditions - do not treat it as a true negative.

Reasoning:

  • Proton pump inhibitors suppress H. pylori urease activity and reduce bacterial load in the stomach and stool, producing false negatives on stool antigen and urea breath testing. The effect is substantial and grows with duration of use.
  • Correct approach: stop the PPI for approximately 2 weeks before retesting (or use a validated serology-free alternative properly). Antibiotics and bismuth need to be held about 4 weeks.
  • Practical wrinkle: he is symptomatic and stopping the PPI will hurt. Options are to (a) hold the PPI, bridge with an H2 blocker or antacids for symptom control, and retest, or (b) treat empirically and plan confirmation of eradication later. Retesting is preferred because it avoids unnecessary antibiotics and resistance selection.
  • Also address the other irritants before declaring treatment failure: NSAIDs and alcohol are both contributing. The partial response to a PPI is expected in ulcer disease but also compatible with functional dyspepsia or NSAID-related injury.

2. He asks point blank whether he needs an endoscopy. Walk through the criteria you actually applied.

Read the worked answer

No endoscopy right now on age alone; but re-evaluate if the picture shifts.

Reasoning:

  • Age threshold: an uninvestigated dyspepsia patient generally warrants endoscopy at age 60 or older (a commonly used cutoff in US guidance; some pathways use 55). At 52 he is below it. Age cutoffs exist because gastric cancer risk rises steeply with age, and they are a proxy for pretest probability, not a biologic rule.
  • Alarm features that would override the age threshold - and he has none: dysphagia or odynophagia, GI bleeding or iron deficiency anemia, unexplained weight loss, persistent vomiting, epigastric mass, family history of upper GI cancer, or dyspepsia that persists despite appropriate empiric therapy.
  • The 8 lb of weight loss deserves attention but currently has an explanation (reduced intake from pain). It should be rechecked; if it continues after symptoms improve, that changes the calculus.
  • A reasonable plan: test-and-treat for H. pylori properly, stop NSAIDs, reduce alcohol, continue PPI for 4-8 weeks, and reassess at that point. Nonresponse to a documented adequate trial is itself an indication for endoscopy at any age.

Document that alarm symptoms were specifically asked about.

3. Assume the repeat test is positive. Choose an eradication regimen, accounting for his history, and describe confirmation.

Read the worked answer

Regimen: 14-day bismuth quadruple therapy - bismuth, a PPI, tetracycline, and metronidazole.

Reasoning:

  • The reported penicillin "allergy" is a childhood rash, which is low-risk and often not a true allergy; however, in the absence of allergy verification, a non-penicillin regimen avoids the risk and avoids a clarithromycin-based triple therapy for a different reason: macrolide resistance.
  • Standard clarithromycin triple therapy has fallen out of favor where clarithromycin resistance exceeds 15%, and it also fails in patients with prior macrolide exposure. Bismuth quadruple therapy is the preferred empiric choice in that setting and in patients with prior macrolide use.
  • Length matters: 14 days is standard for quadruple therapy; 10 days is inferior.
  • Practical points: bismuth turns stools black (warn him), metronidazole requires alcohol avoidance, tetracycline needs separation from dairy and iron, and adherence is the main determinant of success - counsel on all four drugs explicitly.
  • Confirm eradication with a urea breath test or stool antigen at least 4 weeks after finishing antibiotics and after holding the PPI for about 2 weeks. Do not use serology to confirm cure - IgG remains positive for months to years.
  • If eradication fails, do not simply repeat the same regimen; use a different class combination or pursue susceptibility testing.